ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 83 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,959,680 | +61.9% | 5,270,400 | 0.0% | 0.19% | +90.0% |
| Q2 2023 | $5,533,920 | -12.5% | 5,270,400 | 0.0% | 0.10% | -19.4% |
| Q1 2023 | $6,324,480 | -20.0% | 5,270,400 | 0.0% | 0.12% | -17.9% |
| Q4 2022 | $7,905,600 | -52.1% | 5,270,400 | 0.0% | 0.15% | -50.7% |
| Q3 2022 | $16,496,000 | -0.5% | 5,270,400 | +4.2% | 0.31% | +2.0% |
| Q2 2022 | $16,584,000 | -28.1% | 5,056,000 | 0.0% | 0.30% | -19.8% |
| Q1 2022 | $23,055,000 | -36.3% | 5,056,000 | +1.5% | 0.37% | -19.6% |
| Q4 2021 | $36,180,000 | -84.1% | 4,983,500 | -7.4% | 0.46% | -81.4% |
| Q3 2021 | $227,399,000 | – | 5,383,500 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $13,872,375 | 13.22% |
| Alphabet Inc. | 5,680,785 | $8,521,178 | 0.50% |
| 683 Capital Management, LLC | 3,000,000 | $4,500,001 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,906 | 0.32% |
| Slate Path Capital LP | 3,735,000 | $5,602,500 | 0.30% |
| Newtyn Management, LLC | 900,000 | $1,350,000 | 0.28% |
| Orbimed Advisors | 5,270,400 | $7,905,600 | 0.15% |
| Oasis Management Co Ltd. | 348,432 | $522,648 | 0.10% |
| Redmile Group, LLC | 1,440,725 | $2,161,088 | 0.09% |
| Anson Funds Management LP | 154,156 | $231,234 | 0.04% |